Rare cancers

Blijlevens, NicoleThe research focus on personalized supportive care in hematology patients is targeted to stem cell transplant recipients.   read more >>

Bussink, Jan  read more >>

van Ginneken, Bram  read more >>

van der Graaf, WinetteBringing preclinical findings from the lab to the clinic and vice versa  read more >>

van Herpen, CarlaMore than 4 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 186 rare cancers, they represent in total about 22% of all cancer cases. This is more than any single common cancer. Rare cancers are identified as those with an incidence of less than 6 per 100,000 persons per year. Examples of rare cancer are head and neck cancer, sarcoma, thyroid cancer, neuroendocrine cancer, brain tumors, lymphoma, and pediatric cancer. Unfortunately, the average outcome for patients with a rare cancer is inferior to those with more common cancers. Rare cancers pose particular challenges due to their low frequency, including: 1 Late or incorrect diagnosis 2 Lack of access to appropriate therapies and clinical expertise 3 A very limited number of clinical trials due to the small number of patients 4 Lack of interest in the development of new therapies due to limitations in the market 5 Few available registries and tissue banks Our mission is to improve diagnosis and prognosis, to perform (personalized) clinical studies and translational research - from bench to bedside – in patients with rare cancer. This will be performed in relationship with patients advocacy groups, if applicable. Given the rarity of the tumors collaboration with (inter)national centers and partners is vital for the success of this theme.  read more >>

Kaanders, Hans  read more >>

Marres, Henri  read more >>

Merkx, Thijs  read more >>

Oyen, Wim  read more >>

Speksnijder, Caroline  read more >>

Stevens-Kroef, Marian  read more >>

Takes, Robert  read more >>